Video

The BIOSECURE Act Will Be Back… With A Dose Of Tariffs!

Source: Outsourced Pharma

Biopharma executives Robert Discordia, CEO, Equulus Therapeutics, and Reza Oliyai, CEO, Oliyai Consulting, agree we may not have seen the last of the Act … or of tariffs to compound biopharma industry challenges.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)